LiMYZhangYCuiXDLangJCHuYC.Hs-CRP/ALB levels are associated with poor long-term prognosis in patients with STEMI undergoing percutaneous coronary intervention. Angiology. 2026;77(4):458-467. doi:10.1177/00033197251322935
2.
NguyenMTFernandoSSchwarzNTanJTBursillCAPsaltisPJ.Inflammation as a therapeutic target in atherosclerosis. J Clin Med. 2019;8(8):1109. doi:10.3390/jcm8081109
3.
ChienSCChenCYLeuHB, et al. Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease. Int J Cardiol. 2017;241:1-5. doi:10.1016/j.ijcard.2017.04.003
4.
ByrneRARosselloXCoughlanJJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. doi:10.1093/eurheartj/ehad191
5.
MorrowDAAntmanEMCharlesworthA, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031-2037. doi:10.1161/01.CIR.102.17.2031
6.
FoxKAADabbousOHGoldbergRJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333(7578):1091. doi:10.1136/bmj.38985.646481.55
7.
PencinaMJD’AgostinoRBSrD’AgostinoRBJrVasanRS.Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172. doi:10.1002/sim.2929
8.
VickersAJElkinEB.Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-574. doi:10.1177/0272989X06295361
9.
Emerging Risk Factors Collaboration; KaptogeSDi AngelantonioE, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. doi:10.1016/S0140-6736(09)61717-7
10.
RidkerPMEverettBMThurenT, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119-1131. doi:10.1056/NEJMoa1707914
